Neurological predictor scale is associated with academic achievement outcomes in long-term survivors of childhood brain tumors
Survivors of childhood brain tumors exhibit impairments in academic performance and have lower rates of educational attainment compared to healthy same-aged peers. Prior research has demonstrated the concurrent validity of the Neurological Predictor Scale (NPS), a measure that incorporates tumor-related treatments and complications into one cumulative score, in predicting IQ, adaptive functioning, and core neurocognitive skills. The purpose of this study is to determine whether the NPS predicts academic achievement outcomes over and above the effects of individual treatment factors alone.
Sixty-two adult survivors completed four untimed measures of academic achievement from the Woodcock–Johnson III.
NPS scores significantly predicted performance on all four academic measures: Letter Word ID (R2 = − 0.454, p < .01), Calculation (R2 = − 0.494, p < .01), Spelling (R2 = − 0.428, p < .01) and Passage Comprehension (R2 = − 0.447, p < .01). 16% of survivors were impaired on the Letter Word ID, 23% on Calculation, 19% on Spelling, and 11% on Passage Comprehension subtests with impairment defined as z ≤ − 1.5. The NPS predicted academic outcomes over and above chemotherapy, surgery, seizure medication, endocrine dysfunction, hydrocephalus, and radiation on all measures.
This study extends prior research by demonstrating that the NPS is significantly associated with academic achievement in survivors on average 15.9 years after diagnosis. The NPS may be especially helpful in clinical research when studies lack the statistical power to investigate how treatments and neurological conditions individually contribute to outcomes.
KeywordsAcademic achievement Neuropsychological assessment Cancer Pediatrics Neurological complications Treatment
We are grateful to all the individuals and families who participated in this study, as this research would not be possible without their time and effort. We would like to acknowledge the Brain Tumor Foundation for helping share information about this clinical research opportunity with long-term brain tumor survivors. Additionally, we thank the Developmental Neuropsychology Across the Lifespan Research Team for assistance with data acquisition and management. This research was supported by a Research Scholar Grant from the American Cancer Society to TZK (#RSGPB-CPPB-114044). RK was supported by a doctoral fellowship provided by the Georgia State University Second Century Neurogenomics Initiative.
Compliance with ethical standards
Conflict of interest
The authors declare no conflict of interest.
- 5.Hoppe-Hirsch E, Brunet L, Laroussinie F, Cinalli G, Pierre-Kahn A, Renier D, Sainte-Rose C, Hirsch J (1995) Intellectual outcome in children with malignant tumors of the posterior fossa: influence of the field of irradiation and quality of surgery. Child’s Nerv Syst 11(6):340–345CrossRefGoogle Scholar
- 14.Ris MD, Walsh K, Wallace D, Armstrong FD, Holmes E, Gajjar A, Zhou T, Packer RJ (2013) Intellectual and academic outcome following two chemotherapy regimens and radiotherapy for average-risk medulloblastoma: COG A9961. Pediatr Blood Cancer 60(8):1350–1357. https://doi.org/10.1002/pbc.24496 CrossRefGoogle Scholar
- 21.Woodcock RW, McGrew KS, Mather N, Schrank F (2001) Woodcock-Johnson R III NU tests of achievement. Riverside, ItascaGoogle Scholar
- 22.Mather N, Wendling BJ (2015) Essentials of WJ IV tests of achievement. Wiley, New YorkGoogle Scholar
- 23.Cor IS (2016) Ibm spss statistics for windows, version 24.0. IBM Corp, Armonk (NY)Google Scholar
- 29.King T, Wang L, Mao H (2015) White matter integrity disruption in normal appearing white matter: Correlates with long term intellectual outcomes of childhood brain tumor survivors. PLoS ONE 10(7):1–17Google Scholar
- 31.Organization WH (2001) International classification of functioning, disability and health: ICF. World Health Organization, GenevaGoogle Scholar
- 32.Gragert MN, Ris MD (2011) Neuropsychological late effects and rehabilitation following pediatric brain tumor. J Pediatr Rehabil Med 4(1):47–58Google Scholar